Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 27, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - May 27, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/20/17 - Daewoong Seeks FDA Approval for Botulinum Toxin
Daewoong Pharmaceutical's botulinum toxin Nabota is expected to hit the US market by the end of 2018, fueling competition among rivals amid a near monopoly of Allergan.
5/20/17 - Global Feed Additives Market Trends Estimates High Demand by 2024
Feed additives are food supplements, which the farmers provide to their animals for their better growth and yield. These food supplements consist of vitamins, minerals ions, nutrients, proteins and other valuable nutrients in comparison to the natural feed.Sarasota, FL 05/19/2017 Zion Market Research, the market research group announced the a
5/20/17 - Global Whey Protein Products Market Growth, Size Estimated to Increase by 2016 2024
Whey proteins are isolates from whey, that is, a liquid created as a byproduct during cheese production. Whey is full of protein and is therefore used as dietary supplements.Sarasota, FL 05/19/2017 Zion Market Research, the market research group announced the analysis report titled " Whey Protein Products Market: Industry Perspective, Compreh
5/20/17 - Investment Plan for Europe: EIB grants financing to Biofrontera
LUXEMBOURG, 19 May 2017/ PRNewswire Policy/ The European Investment Bank will grant financing of up to EUR 20 million to the German biopharmaceutical company Biofrontera AG. EFSI is the central pillar of the Investment Plan for Europe, in which EIB Group and the European Commission are strategic partners. Ambroise Fayolle, Vice President of
5/20/17 - New Lenox hospital offers new implant for foot surgery
Anne McCall is always on her feet. As the medical director for radiation oncology at the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, it's no surprise she walks all day. The new implant, called the Cartiva Synthetic Cartilage Implant, received FDA approval about a year ago.
5/20/17 - North American Nuclear Medicine / Radiopharmaceuticals Market Worth 2.98 Billion USD by 2020
North American Nuclear Medicine/Radiopharmaceuticals Market categories the Global Market by Application, Type& GeographySeattle, WA 05/19/2017 The report " North American Nuclear Medicine/Radiopharmaceuticals Market by Type, by Application- Forecasts to 2020", analyzes and studies the major market drivers, restraints/challenges, and opportuni
5/20/17 - Restricting pharmaceutical reps' marketing tactics changes physician prescribing behavior
By a News Reporter-Staff News Editor at Marketing Weekly News New research shows that limiting how pharmaceutical sales representatives can market their products to physicians changes their drug prescribing behaviors. A team, led by the University of California, Los Angeles' Ian Larkin and Carnegie Mellon University's George Loewenstein, examined
5/20/17 - UC San Diego VC Partner Osage Invests in Antiva
Antiva Biosciences, a spinout of UC San Diego, closed a $22 M Series C financing in March. Osage University Partners, a venture capital firm partnered with UC San Diego that invests exclusively in startups that are commercializing university research, invested in this round alongside Brace Pharma Capital, NS Investment, and Alexandria Venture Inves
5/19/17 - "Expandable Endoscopic Hoods and Related Methods of Use" in Patent Application Approval Process (USPTO 20170112359)
By a News Reporter-Staff News Editor at Health& Medicine Week A patent application by the inventors RAYBIN, Samuel; CHENG, Ruth; SMITH, Paul; SUON, Naroun, filed on October 14, 2016, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigne
5/19/17 - "Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use" in Patent Application Approval Process (USPTO 20170112821)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Horn, Gerald, filed on January 9, 2017, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution. Due to the incr
5/19/17 - "Pharmaceutical Compositions Comprising Gels and Methods for Fabricating Thereof" in Patent Application Approval Process (USPTO 20170112936)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Karolchyk, John Scott; Saadeh, Dennis Elias, filed on January 5, 2017, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company
5/19/17 - "Therapeutic Combinations of Sesquiterpenes and Flavonoids" in Patent Application Approval Process (USPTO 20170112802)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Yamaguchi, Masayoshi, filed on October 14, 2016, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Primus Pharmaceuticals, Inc.. Baicalin and
5/19/17 - "Timed, Pulsatile Release Systems" in Patent Application Approval Process (USPTO 20170112774)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Venkatesh, Gopi M., filed on January 9, 2017, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Adare Pharmaceuticals, Inc.. The following qu
5/19/17 - Abbott Laboratories' Trademark Application for "ACCELERATOR" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ACCELERATOR" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, Abbott Labor
5/19/17 - Abbott Laboratories' Trademark Application for "TRANSFORMATION RISING" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "TRANSFORMATION RISING" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, Ab
5/19/17 - Abeona Therapeutics to Present at Multiple Upcoming Conferences
ABO-102 gene therapy program for Sanfilippo syndrome Type A: Abeona announced top-line data for Phase 1/ 2 MPS IIIA gene therapy trial at ASGCT Positive dose response in central nervous system with 60.7%+/- 8.8% reduction of disease-causing heparan sulfate GAG observed in Cohort 2 Reduction of disease manifestation observed in decreased liver v
5/19/17 - ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition
ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition Item 2.02 Results of Operations and Financial Condition On May 18, 2017 we issued a press release announcing the announced that we completed enrollment and initiated dosing in a second Phase 1 human pharmacokinetic trial of LTX-04, our lead developm
5/19/17 - Acute Market Reports: 2017 Global market Demand Generic Drug Market - Global Industry Analysis, Market Size, Share, Growth, Trend, Market Capacity, Production, Revenue, Price and Gross Margin and Forecast 2022 by QY Research Reports
The United States Generic Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Generic Drug industry. The Generic Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. The report focuses on
5/19/17 - Acute Market Reports: New Market Research Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trend, Market Capacity, Production, Revenue, Price and Gross Margin and Forecast 2022 by QY Research Reports
This report studies Vaccines in Global and China market, focuses on top manufacturers in global and China market, involving Vaccines price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Vaccines in USA, EU, China, Japan, India and Southeast Asia, foreca
5/19/17 - Aeterna Zentaris to Announce First Quarter 2017 Financial and Operating Results on May 8, 2017
By a News Reporter-Staff News Editor at Drug Week Aeterna Zentaris Inc. will announce its first quarter 2017 financial and operating results after market close on Monday, May 8, 2017. The Company will host a conference call and webcast to discuss these results on Tuesday, May 9, 2017 at 8:30 a.m. Eastern Time. About Aeterna Zentaris Inc. Aeterna
5/19/17 - Agendia's MammaPrint Now Included in First Coast Coverage for Medicare Breast Cancer Patients in Florida, Puerto Rico and the Virgin Islands
By a News Reporter-Staff News Editor at Insurance Weekly News Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces that First Coast Service Options Inc., the Medicare contractor for Florida, Puerto Rico, and the Virgin Islands, has revised its Local Coverage Determination for gene expression profiling
5/19/17 - Agios to Present Updated Clinical Data from PKR Activator AG-348 at EHA [T-break Tech (Middle East)]
-Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic diseases, today announced that updated clinical data from the fully enrolled, ongoing Phase 2 study of AG-348 in adults with pyruvate kinase deficiency, a rare, potentially debilitating, congenital anemia, will be presented at the 22nd Congress of the Europea
5/19/17 - AMCP Joins 10 Organizations in Joint Comment Letter to the FDA on Draft Interchangeability Guidance
All of the undersigned groups share the FDA's deep commitment to the development of a robust biosimilars market for patients, and greatly appreciate all the work the agency has done in creating certainty around the approval pathway created by the Biologics Price Competition and Innovation Act, including the long anticipated proposed guidance detail
5/19/17 - Amicus Therapeutics Announces Planned Analysis of Primary Endpoints in Phase 3 Epidermolysis Bullosa Study
Amicus Therapeutics, Inc., has completed the analysis plan for the primary endpoints in the blinded ongoing Phase 3 clinical study of the novel topical medicine SD-101 for epidermolysis bullosa. Time to Wound Closure is as an acceptable efficacy endpoint for wound-related diseases, per FDA guidance. 1. Jay Barth, MD, Chief Medical Officer of Amic
5/19/17 - An Application for the Trademark "SYMLINPEN" Has Been Filed by AstraZeneca Pharmaceuticals
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "SYMLINPEN" by Marc Stanislawczyk, representing AstraZeneca Pharmaceuticals. The owner/registrar information for this application is: Marc Stanislawczyk, AstraZeneca...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415